{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:56:22Z","timestamp":1790538982673,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2017.08.058","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T18:16:23Z","timestamp":1504808183000},"page":"7190-7200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Considerations for use of Ebola vaccine during an emergency response"],"prefix":"10.1016","volume":"37","author":[{"given":"Jenny A.","family":"Walldorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Cloessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri B.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind J.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Redd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Marston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.08.058_b0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJMsr1513109","article-title":"After Ebola in West Africa \u2014 unpredictable risks, preventable epidemics","volume":"375","author":"Team","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.058_b0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2334-11-357","article-title":"Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned","volume":"11","author":"Borchert","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0015","first-page":"271","article-title":"Ebola haemorrhagic fever in Zaire, 1976","volume":"56","author":"World Health Organization","year":"1978","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.08.058_b0020","first-page":"1077","article-title":"Ebola virus disease cases among health care workers not working in Ebola treatment units\u2013Liberia, June-August, 2014","volume":"63","author":"Matanock","year":"2014","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.08.058_b0025","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1086\/514320","article-title":"Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995","volume":"179","author":"Kerstiens","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.08.058_b0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/514308","article-title":"Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients","volume":"179","author":"Bwaka","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.08.058_b0035","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/514306","article-title":"The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Khan","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0040","unstructured":"Summary of the April 2017 meeting of the Strategic Advisory Group of Experts on Immunization. Releve epidemiologique hebdomadaire\/Weekly epidemiological record. 2017;92:241."},{"key":"10.1016\/j.vaccine.2017.08.058_b0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.coviro.2016.03.008","article-title":"On a path to accelerate access to Ebola vaccines: the WHO's research and development efforts during the 2014\u20132016 Ebola epidemic in West Africa","volume":"17","author":"Henao-Restrepo","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2017.08.058_b0050","unstructured":"WHO. Global Ebola Vaccine Implementation Team (GEVIT) Practical Guidance on the Use of Ebola Vaccine in an outbreak response. Draft Guidance: <http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/gevit-guide\/en\/>. May 2016."},{"key":"10.1016\/j.vaccine.2017.08.058_b0055","unstructured":"Centers for Disease Control and Prevention. Outbreaks Chronology: Ebola Virus Disease. <http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/history\/chronology.html>."},{"key":"10.1016\/j.vaccine.2017.08.058_b0060","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(95)90925-7","article-title":"Isolation and partial characterisation of a new strain of Ebola virus","volume":"345","author":"Le Guenno","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.058_b0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/cid\/civ531","article-title":"Time from infection to disease and infectiousness for Ebola virus disease, a systematic review","volume":"61","author":"Velasquez","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.08.058_b0070","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1086\/514284","article-title":"Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Dowell","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2017.08.058_b0075","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1086\/520545","article-title":"Assessment of the risk of Ebola virus transmission from bodily fluids and fomites","volume":"196","author":"Bausch","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0080","unstructured":"World Health Organization. Guidance for Immunization Programmes in the Africa Region in the context of Ebola, Informational Note, 30 March 2015. In: World Health Organization ARO. Informational Note2015."},{"key":"10.1016\/j.vaccine.2017.08.058_b0085","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(15)61446-5","article-title":"Age-specific incidence of Ebola virus disease","volume":"386","author":"Glynn","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.058_b0090","first-page":"73","article-title":"Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"key":"10.1016\/j.vaccine.2017.08.058_b0095","first-page":"247","article-title":"Ebola haemorrhagic fever in Sudan, 1976","volume":"56","author":"World Health Organization","year":"1978","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.08.058_b0100","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1086\/514307","article-title":"Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995","volume":"179","author":"Tomori","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.08.058_b0105","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/514311","article-title":"Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival","volume":"179","author":"Sadek","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.08.058_b0110","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/514286","article-title":"Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure","volume":"179","author":"Roels","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0115","first-page":"1168","article-title":"Ebola virus disease in health care workers\u2013Sierra Leone, 2014","volume":"63","author":"Kilmarx","year":"2014","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"key":"10.1016\/j.vaccine.2017.08.058_b0120","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3201\/eid1607.091525","article-title":"Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007\u20132008","volume":"16","author":"Wamala","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0125","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1411099","article-title":"Ebola virus disease in the Democratic Republic of Congo","volume":"371","author":"Maganga","year":"2014","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2017.08.058_b0130","unstructured":"Forrester JD, Hunter JC, Pillai SK, Arwady MA, Ayscue P, Matanock A, et al. Cluster of Ebola cases among Liberian and U.S. health care workers in an Ebola treatment unit and adjacent hospital \u2013 Liberia, 2014. MMWR Morbidity Mortality Weekly Rep 2014;63:925-9."},{"key":"10.1016\/j.vaccine.2017.08.058_b0135","first-page":"386","article-title":"Ebola transmission linked to a single traditional funeral ceremony \u2013 Kissidougou, Guinea, December 2014-January 2015","volume":"64","author":"Victory","year":"2015","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"key":"10.1016\/j.vaccine.2017.08.058_b0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/M14-2255","article-title":"Effect of Ebola progression on transmission and control in Liberia","volume":"162","author":"Yamin","year":"2015","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.vaccine.2017.08.058_b0145","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciw601","article-title":"Resurgence of Ebola virus disease in guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days","volume":"63","author":"Diallo","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0150","doi-asserted-by":"crossref","first-page":"150019","DOI":"10.1038\/sdata.2015.19","article-title":"A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making","volume":"2","author":"Van Kerkhove","year":"2015","journal-title":"Sci Data"},{"key":"10.1016\/j.vaccine.2017.08.058_b0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1473-3099(14)71075-8","article-title":"Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study","volume":"15","author":"Faye","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0160","doi-asserted-by":"crossref","unstructured":"Althaus CL. Ebola superspreading. Lancet Infect Dis 15:507-8.","DOI":"10.1016\/S1473-3099(15)70135-0"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.08.058_b0165","doi-asserted-by":"crossref","first-page":"S761","DOI":"10.1093\/infdis\/jir294","article-title":"Filovirus outbreak detection and surveillance: lessons from Bundibugyo","volume":"204","author":"MacNeil","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0170","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1073\/pnas.1614595114","article-title":"Spatial and temporal dynamics of superspreading events in the 2014\u20132015 West Africa Ebola epidemic","volume":"114","author":"Lau","year":"2017","journal-title":"Proc Natl Acad Sci United States of America"},{"key":"10.1016\/j.vaccine.2017.08.058_b0175","doi-asserted-by":"crossref","unstructured":"International Ebola Response T, Agua-Agum J, Ariyarajah A, Aylward B, Bawo L, Bilivogui P, et al. Exposure patterns driving ebola transmission in West Africa: A retrospective observational study. PLoS Med. 2016;13:e1002170.","DOI":"10.1371\/journal.pmed.1002170"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.08.058_b0180","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Rowe","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0185","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3201\/eid1612.100627","article-title":"Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda","volume":"16","author":"MacNeil","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0190","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci United States of America"},{"key":"10.1016\/j.vaccine.2017.08.058_b0195","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.08.058_b0200","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.08.058_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.09.001","article-title":"Clinical features and pathobiology of Ebolavirus infection","volume":"55","author":"Ansari","year":"2014","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.vaccine.2017.08.058_b0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature17949","article-title":"Unique human immune signature of Ebola virus disease in Guinea","volume":"533","author":"Ruibal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.08.058_b0215","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/14760584.2014.885841","article-title":"Ebola virus vaccines: an overview of current approaches","volume":"13","author":"Marzi","year":"2014","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.058_b0220","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2016.1178068","article-title":"Ebola Virus Vaccines \u2013 reality or fiction?","author":"Mire","year":"2016","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.058_b0225","article-title":"Vaccines against 'the other' Ebolavirus species","volume":"1\u20138","author":"Kozak","year":"2016","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.058_b0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/2051013615611017","article-title":"Clinical development of Ebola vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Therap Adv Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.058_b0235","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1586\/14760584.2015.1083429","article-title":"Ebola virus vaccine: benefit and risks of adenovirus-based vectors","volume":"14","author":"Mennechet","year":"2015","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.058_b0240","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/14760584.2016.1187566","article-title":"Ebola virus disease candidate vaccines under evaluation in clinical trials","volume":"15","author":"Martins","year":"2016","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.058_b0245","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","author":"Henao-Restrepo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.058_b0250","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2017.08.058_b0255","unstructured":"Samai M, Schuchat A, Fofanah AB. Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE). American Society of Tropical Medicine and Hygiene Annual Meeting. Atlanta, Georgia November 17, 2016."},{"key":"10.1016\/j.vaccine.2017.08.058_b0260","unstructured":"Davey RT. PREVAIL I: A randomized controlled safety and immunogenicity trial of two different vaccines against Ebola virus. Presented at 8th International Symposium on Filoviruses, September 12\u201315, 2016, Antwerp, Belgium; 2016."},{"key":"10.1016\/j.vaccine.2017.08.058_b0265","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia ankara-vectored ebola vaccines: a randomized clinical trial","volume":"315","author":"Milligan","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2017.08.058_b0270","unstructured":"Meeting of the Strategic Advisory Group of Experts on immunization, October 2015 \u2013 conclusions and recommendations. Releve epidemiologique hebdomadaire \/ Weekly epidemiological record. 2015;90:681-99."},{"key":"10.1016\/j.vaccine.2017.08.058_b0275","unstructured":"WHO. Global manual on surveillance of adverse events following immunization. Geneva, Switzerland. March 2016."},{"key":"10.1016\/j.vaccine.2017.08.058_b0280","unstructured":"Gavi. Ebola vaccine purchasing commitment from Gavi to prepare for future outbreaks. <http:\/\/www.gavi.org\/library\/news\/press-releases\/2016\/ebola-vaccine-purchasing-commitment-from-gavi-to-prepare-for-future-outbreaks\/> 20 January 2016."},{"key":"10.1016\/j.vaccine.2017.08.058_b0285","unstructured":"WHO. International Coordinating Group (ICG) on Vaccine Provision, Online Q&A. 17 June 2016."},{"key":"10.1016\/j.vaccine.2017.08.058_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.06.026","article-title":"Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: results of a national household survey","author":"Irwin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.058_b0295","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.vaccine.2016.02.046","article-title":"Knowledge and attitudes about Ebola vaccine among the general population in Sierra Leone","volume":"34","author":"Huo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.058_b0300","doi-asserted-by":"crossref","first-page":"e0003838","DOI":"10.1371\/journal.pntd.0003838","article-title":"Acceptability and willingness-to-pay for a hypothetical Ebola virus vaccine in Nigeria","volume":"9","author":"Ughasoro","year":"2015","journal-title":"PLoS Neglect Trop Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0305","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4269\/ajtmh.16-0206","article-title":"Health-care workers' perspectives on Ebola virus vaccine: a focus group and in-depth interview interventional study","volume":"95","author":"Esangbedo","year":"2016","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.vaccine.2017.08.058_b0310","doi-asserted-by":"crossref","unstructured":"O'Brien KL, Binka F, Marsh K, Abramson JS. Mind the gap: jumping from vaccine licensure to routine use. The Lancet 387:1887-9.","DOI":"10.1016\/S0140-6736(16)30394-4"},{"key":"10.1016\/j.vaccine.2017.08.058_b0315","doi-asserted-by":"crossref","first-page":"e0004802","DOI":"10.1371\/journal.pntd.0004802","article-title":"Next steps for Ebola vaccination: deployment in non-epidemic, high-risk settings","volume":"10","author":"Skrip","year":"2016","journal-title":"PLoS Neglect Trop Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0320","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/mi.2008.27","article-title":"Immune privilege or privileged immunity?","volume":"1","author":"Forrester","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.08.058_b0325","first-page":"479","article-title":"Possible sexual transmission of Ebola virus \u2013 Liberia, 2015","volume":"64","author":"Christie","year":"2015","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"key":"10.1016\/j.vaccine.2017.08.058_b0330","article-title":"Ebola RNA persistence in semen of Ebola virus disease survivors\u2014preliminary report","volume":"151014140118009","author":"Deen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.058_b0335","article-title":"Molecular evidence of sexual transmission of Ebola virus","volume":"151014140151006","author":"Mate","year":"2015","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.08.058_b0340","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/514291","article-title":"Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995","volume":"179","author":"Rodriguez","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0345","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/cid\/ciu981","article-title":"Sexual and mother-to-child transmission of Ebola virus in the postconvalescent period","volume":"60","author":"Sonnenberg","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0350","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw078","article-title":"New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors","author":"Sow","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0355","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.058_b0360","doi-asserted-by":"crossref","unstructured":"Billioux BJ, Nath A, Stavale EJ, Dorbor J, Fallah MP, Sneller MC, et al. Cerebrospinal fluid examination in survivors of Ebola virus disease. JAMA Neurol. 2017.","DOI":"10.1001\/jamaneurol.2017.1460"},{"key":"10.1016\/j.vaccine.2017.08.058_b0365","doi-asserted-by":"crossref","unstructured":"Kamali A, Jamieson DJ, Kpaduwa J, Schrier S, Kim M, Green NM, et al. Pregnancy, Labor, and delivery after Ebola virus disease and implications for infection control in obstetric services, United States. Emerg Infect Dis 2016;22.","DOI":"10.3201\/eid2207.160269"},{"key":"10.1016\/j.vaccine.2017.08.058_b0370","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3201\/eid2204.151880","article-title":"Ebola virus in breast milk in an Ebola virus-positive mother with twin babies, Guinea, 2015","volume":"22","author":"Nordenstedt","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0375","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.3.21017","article-title":"Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient","volume":"20","author":"Moreau","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2017.08.058_b0380","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/527453a","article-title":"Ebola: Hidden reservoirs","volume":"527","author":"Heeney","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.08.058_b0385","doi-asserted-by":"crossref","first-page":"15818","DOI":"10.1038\/srep15818","article-title":"Modeling the effect of comprehensive interventions on Ebola virus transmission","volume":"5","author":"Shen","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.08.058_b0390","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3201\/eid2201.151410","article-title":"Effectiveness of ring vaccination as control strategy for Ebola virus disease","volume":"22","author":"Kucharski","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0395","doi-asserted-by":"crossref","first-page":"e0005093","DOI":"10.1371\/journal.pntd.0005093","article-title":"Containing Ebola at the source with ring vaccination","volume":"10","author":"Merler","year":"2016","journal-title":"PLoS Neglect Trop Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0400","doi-asserted-by":"crossref","first-page":"e0003794","DOI":"10.1371\/journal.pntd.0003794","article-title":"Harnessing case isolation and ring vaccination to control Ebola","volume":"9","author":"Wells","year":"2015","journal-title":"PLoS Neglect Trop Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0405","doi-asserted-by":"crossref","first-page":"e1175","DOI":"10.1371\/journal.pntd.0001175","article-title":"Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus","volume":"5","author":"Macneil","year":"2011","journal-title":"PLoS Neglect Trop Dis"},{"key":"10.1016\/j.vaccine.2017.08.058_b0410","doi-asserted-by":"crossref","first-page":"e0118881","DOI":"10.1371\/journal.pone.0118881","article-title":"Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles","volume":"10","author":"Warfield","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.08.058_b0415","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-Reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.08.058_b0420","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.08.058_b0425","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species","volume":"6","author":"Hensley","year":"2010","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2017.08.058_b0430","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/CVI.00467-09","article-title":"Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector","volume":"17","author":"Pratt","year":"2010","journal-title":"Clin Vaccine Immunol: CVI."},{"key":"10.1016\/j.vaccine.2017.08.058_b0435","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.2016.20644","article-title":"Immune responses to novel adenovirus type 26 and modified vaccinia virus ankara-vectored Ebola vaccines at 1 year","volume":"317","author":"Winslow","year":"2017","journal-title":"Jama"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:36Z","timestamp":1759401396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17311568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":87,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X17311568"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations for use of Ebola vaccine during an emergency response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}